Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report.AuthorsHebart, Holger; Lang, Peter; Woessmann, WilhelmAbstractA letter to the editor is presented in response to the article "Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis" by L. Mussolin in the previous issue.SubjectsLYMPHOMA diagnosis; ANAPLASTIC lymphoma kinase; ANTINEOPLASTIC agents; THERAPEUTIC use of monoclonal antibodies; DISEASE remission; T-cell lymphomaPublicationAnnals of Internal Medicine, 2016, Vol 165, Issue 8, p607ISSN0003-4819Publication typecase studyDOI10.7326/L16-0037